Clarius Mobile Health shares surge 10.65% intraday after announcing FY2025 profitability, 20% revenue growth, and FDA-cleared AI models.

Mobile-health surged 10.65% intraday following Clarius Mobile Health’s announcement of FY2025 profitability, 20% year-over-year revenue growth, and two new FDA-cleared AI ultrasound models. The news reinforced the company’s leadership in AI-powered point-of-care ultrasound, with expanded global distribution and partnerships in pharmaceutical clinical trials. Other mobile health-related news, such as a Brazilian sanitation app or Walmart’s wellness tour, lacked direct relevance to the stock’s movement. The intraday rally aligns with the company’s strategic milestones and validation of its AI-driven medical imaging innovations.